Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 July 2006

Screening for human papillomavirus (HPV) in Egyptian women by the second-generationhybrid capture (HC II) test.

Mohamed Talaat Abdel Aziz, Mohamed Zayed Abdel Aziz, Hazem mahmoud Atta, Olaf Gamil Shaker, Manal Mohsen Abdel Fattah, Gamal Ahmed Mohsen, Hanan Hosni Ahmed, Douaa Ahmed El Derwi

Med Sci Monit 2006; 12(7): MT43-49 :: ID: 452213

Abstract

Background: HPV infection is the main cause of cervical cancer and cervicalintraepithelial neoplasia worldwide. The second-generation HC II test is a liquid hybridization assaydesigned to detect 18 HPV types. The aim of the present study was to detect the rate of HPV infectionand its various genotypes among Egyptian women. Material/Methods: We evaluated 166 Egyptian women. Theywere classified according to cytology into those with normal cytology, chronic nonspecific cervicitis,and squamous intraepithelial lesions (SILs). Results: The overall prevalence of HPV DNA in the studiedgroups was 15.06% (25/166). Among the 25 HPV-positive women, 16 (64%) were infected with high-risk HPVtypes, 4 (16%) with low risk HPV types, while 5 (20%) had both types. Twenty-one (84%) of the infectedwomen harbored at least one high-risk HPV type, while 9 (36%) harbored at least one low-risk HPV type.Values of HPV viral load for low-risk HPV infection showed no significant difference in the normal andchronic nonspecific cervicitis groups. But when HPV viral load of high-risk HPV infection was comparedin the normal, chronic nonspecific cervicitis, and SIL groups, a significant difference was found. Thesame was detected between chronic nonspecific cervicitis and SIL and between normal cytology and SIL,suggesting an association between viral load and risk of SIL and, accordingly, cancer. Conclusions: Itmay be concluded that HPV testing using the HC II assay is a useful tool when combined with cytologyin the diagnosis of high-risk HPV viral types in apparently normal tissues.

Keywords: Egypt, DNA, Viral - analysis, Mass Screening - methods, Nucleic Acid Hybridization - methods, Papillomaviridae - isolation & purification

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750